Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2015 / Cilt: 68 - Sayı: 1

An Investigation on Effects of Pioglitazone in the Heart Function from Rats with Metabolic Syndrome by Using Electrophysiological Techniques

Pioglitazonun Metabolik Sendromlu Sıçan Kalp Fonksiyonuna Etkisinin Elektrofizyolojik Yöntemlerle İncelenmesi

Pages
1–7
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally, both agents caused a small but significant increase on serum TAS levels (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Metabolic syndrome (MetS), generally characterized with insulin-resistance, leads to severe cardiovascular disorders, however, the underlying mechanisms of this syndrome has not yet been fully determined.
📊
Key Findings & Data:Second, for a comparative study to determine whether MetS-induced heart dysfunction is due to increased oxidative stress, we used a known antioxidant (quercetin) to MetS rats for the same period.
💡
Conclusion & Impact:Additionally, both agents caused a small but significant increase on serum TAS levels (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Metabolic syndrome (MetS), generally characterized with insulin-resistance, leads to severe cardiovascular disorders, however, the underlying mechanisms of this syndrome has not yet been fully determined. In addition, there are some controversies related with unti-diabetic agents used for treatment of MetS-induced complications, including their aggravating effects on the depressed cardiac function. Therefore, in this study, we first aimed to investigate the effects of pioglitazone, known as a insulinsensitizer, on MetS-induced heart dysfunction. Second, for a comparative study to determine whether MetS-induced heart dysfunction is due to increased oxidative stress, we used a known antioxidant (quercetin) to MetS rats for the same period. Material and Methods: Total 28 male Wistar rats (3 months) were grouped as control group, (Con), MetS group (MetS; added 32% sucrose to drinking water for 18-week), MetS group supplemented with pioglitazone (Piog; 30 mg/kg/day via gavage for 2-week, from 16th-week of MetS-group) and MetS with quercetin (Quer; 75 mg/kg/day via gavage for 2-weeks from 16th-week of MetS group). All rats were fed with standard rat-diet and tap water at standard condition. At the end of experimental period, the body weights and blood glucose levels, and total oxidative status (TOS) and total antioxidant status (TAS) in serum by using special kits were measured for all animals. By using Langendorff-isolated-organ system, left ventricle pressure changes (LVPC) were measured in isolated hearts. The basal level of intracellular free Ca2+ ([Ca2+]i) and Ca2+ transients under electrical-situmulation (under action-potential) were measured in freshly isolated cardiomyocytes by enzymatic-method (loaded with Ca2+-sensitive fluorescence dye, Fura-2AM). Results and Discussion: Either pioglitazone or quercetin application have positive effects on body weight and high blood sugar levels in MetS-group rats. Additionally, both agents caused a small but significant increase on serum TAS levels (p

Özet

Amaç: Metabolik sendrom (MetS), genellikle insülin-direnci ile karakterize, kardiyovasküler sistem sorunlarıyla seyreden, mekanizması henüz tam olarak anla?ılamamı? bir hastalıktır. Diğer yandan, MetS-indüklü komplikasyonların tedavisinde kullanılan bazı ilaçların, kardiyovasküler sistem sorunlarına ek sorunlar getirebildiği tartı?ılmaktadır. Bu çalı?mada, ilk olarak insülin-duyarla?tırıcı olarak bilinen pioglitazonun, MetSindüklü bozulan kalp fonksiyonu üzerindeki etkisini incelemeyi hedefledik. İkinci olarak, MetS-indüklü etkinin artan oksidatif stres üzerinden olup olmadığını göstermek amacıyla, bilinen bir antioksidan (kuersetin) uygulayarak sonuçları kar?ıla?tırmalı olarak incelenmesi hedefledik. Materyal ve Metodlar: Toplam 28-adet erkek Wistar-türü sıçanlar (3 aylık), kontrol grubu (Kon), MetS grubu (MetS; 18-hafta içme suyuna %32 sükroz eklenerek olu?turulmu?tur), MetS-grubunun 16. haftasından itibaren 2-hafta süre ile ya pioglitazon uygulanmı? MetS-grubu (Piog; 30 mg/kg/gün), ya da kuersetin uygulanmı? MetS grubu (Kuer; 75 mg/kg/gün) olarak düzenlenmi?tir. Tüm hayvanlar standart ko?ullarda normal sıçan yemi ile beslenmi?tir. Çalı?ma sonunda, hayvanların vücut ağırlıkları, kan ?ekeri ile serum toplam oksitatif stres (TOS) ve antioksidan (TAS) durumları özel kit ile ölçülmü?tür. Langendorff-izole-organ-sisteminde sol ventrikül içi basınç deği?imleri (SVBD) ile, enzimatik yöntemle kalbin ventrikülünden izole edilen kardiyomiyositlerde (Ca2+-duyarlı florofor Fura-2AM ile boyanmı?) hücre-içi bazal serbest-Ca2+ seviyesi ([Ca2+]i) ve elektriksel-uyarı altında (aksiyon-potansiyeli sırasında) geçici [Ca2+]i deği?imleri incelenmi?tir. Bulgular ve Sonuç: Pioglitazon veya kuersetin, MetS-grubunda kilo artı?ı ve yüksek kan ?ekeri üzerinde pozitif etkiler gösterirken, her iki ajan artmı? olan serum TOS seviyelerini deği?tirememi?, buna kar?ılık küçük fakat anlamlı seviyede TAS seviyesinin yükselmesine neden olmu?lardır (p

🔖

Cite This Article

TUNCAY, E., TUTAR, M. F., TURAN, B., AYDIN, İ., DOĞAN, M., TOY, A., OLGAR, Y., OKATAN, E. N., DEĞİRMENCİ, S., AKSU, S., BIÇAKÇI, E., GÜNDÜZ, A. (2022). An Investigation on Effects of Pioglitazone in the Heart Function from Rats with Metabolic Syndrome by Using Electrophysiological Techniques. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 68 - Sayı: 1, 1–7. https://ajindex.com/articles/443764

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Reaven GM, Chang H, Hoffman BB. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Diabetes 1988;37: 28-32
  2. Hanson RL, Imperatore G, Bennett PH, et al. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002;51: 3120-3127
  3. Meigs JB, Nathan DM, D'Agostino RB, Sr., Wilson PW, Framingham Offspring S. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25: 1845-1850
  4. Gundogan K, Bayram F, Capak M, et al. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Metab Syndr Relat Disord. 2009;7: 427-434
  5. Demiral Y, Soysal A, Can Bilgin A, et al. The association of job strain with coronary heart disease and metabolic syndrome in municipal workers in Turkey. J Occup Health 2006;48: 332-338
  6. Onat A, Yuksel M, Koroglu B, et al. [Turkish Adult Risk Factor Study survey 2012: overall and coronary mortality and trends in the prevalence of metabolic syndrome]. Turk Kardiyol Dern Ars 2013;41: 373-378
  7. Onat A. On the coronary heart disease mortality in Turkey. Atherosclerosis 2002;163: 203-204
  8. Soysal A, Demiral Y, Soysal D, et al. The prevalence of metabolic syndrome among young adults in Izmir, Turkey. Anadolu Kardiyol Derg 2005;5: 196-201
  9. Panchal SK, Poudyal H, Iyer A, et al. High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 2011;57: 51-64
  10. Davidoff AJ, Mason MM, Davidson MB, et al. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab 2004;286: E718- 724
  11. Fang ZY, Schull-Meade R, Downey M, et al. Determinants of subclinical diabetic heart disease. Diabetologia 2005;48: 394- 402. 12. de Freitas EV, Brandao AA, Pozzan R, et al. Study of the intima-media thickening in carotid arteries of healthy elderly with high blood pressure and elderly with high blood pressure and dyslipidemia. Clin Interv Aging 2008;3: 525-534
  12. Gonsolin D, Couturier K, Garait B, et al. High dietary sucrose triggers hyperinsulinemia, increases myocardial betaoxidation, reduces glycolytic flux and delays post-ischemic contractile recovery. Mol Cell Biochem 2007;295: 217-228
  13. Pang PS, Cleland JG, Teerlink JR, et al. A proposa